Market Place
Sourcing Support
GNT Pharma Gets Nod for Ph3 Stroke Trial of Nelonemdaz™Therapy
24 Jul 2025 //
PR NEWSWIRE
GNT Pharma Announces Approval of IND for PIII Trial of Nelonemdaz
08 Sep 2021 //
GLOBENEWSWIRE
GNT Eyes Unmet Need As Novel Ischemic Stroke Therapy Moves To Phase III
31 Aug 2021 //
PHARMA INTELLIGENCE
GNT Pharma Announces Positive Top-Line Results in a Phase II Study
14 Oct 2020 //
BUSINESSWIRE
GNT Pharma Announces Positive Top-Line Results in a Phase II Study of Nelonemdaz
14 Oct 2020 //
BUSINESSWIRE
Distributed Bio Collaborates With Washington University School of Medicine
14 Jan 2020 //
BUSINESS WIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.